ABL2 and osteosarcoma: Kinase targets found in the analysis were for osteosarcoma (KIT), Ewing’s sarcoma (ALK), undifferentiated pleomorphic sarcoma (JAK2, ABL2), alveolar rhabdomyosarcoma (NTRK1), and leiomyosarcoma (ALK).